DNAprint Genomics (DNAG)

[Porgie Tirebiter]

I looked at ACTC's last 10Q filed last July. This company reminds me a little of DNAPrint. I'm still going to stick with my thesis that we are seeing a "mini-bubble" in micro-cap stocks perceived to have something to do with "stem-cell" or "personalized medicine" or whatever you want to call it. There is a remarkable rise in price for the whole sector so we cannot connect this with any improvement to the fortunes of DNAPrint.

As to the financial health of both of these companies, well let's just say there isn't much of it.

These are just my opinions.

And "Dude" is an insult. Please refrain.